Somnomed Limited Stock Performance
| SOMNF Stock | USD 0.41 0.03 6.82% |
SomnoMed holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of 2.92, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, SomnoMed will likely underperform. Use SomnoMed Limited skewness, as well as the relationship between the day median price and relative strength index , to analyze future returns on SomnoMed Limited.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in SomnoMed Limited are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, SomnoMed reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 21.1 M | |
| Total Cashflows From Investing Activities | -8.5 M |
SomnoMed |
SomnoMed Relative Risk vs. Return Landscape
If you would invest 17.00 in SomnoMed Limited on November 28, 2024 and sell it today you would earn a total of 24.00 from holding SomnoMed Limited or generate 141.18% return on investment over 90 days. SomnoMed Limited is currently producing 2.2754% returns and takes up 16.2941% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than SomnoMed, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SomnoMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SomnoMed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as SomnoMed Limited, and traders can use it to determine the average amount a SomnoMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1396
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | SOMNF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.29 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.28 actual daily | 45 55% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average SomnoMed is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SomnoMed by adding it to a well-diversified portfolio.
SomnoMed Fundamentals Growth
SomnoMed Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of SomnoMed, and SomnoMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SomnoMed Pink Sheet performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0452 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 62.24 M | |||
| Shares Outstanding | 78.56 M | |||
| Price To Earning | 5.61 X | |||
| Price To Book | 4.09 X | |||
| Price To Sales | 1.06 X | |||
| Revenue | 72.58 M | |||
| EBITDA | 524.53 K | |||
| Cash And Equivalents | 15.64 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 2.01 M | |||
| Debt To Equity | 0.43 % | |||
| Book Value Per Share | 0.34 X | |||
| Cash Flow From Operations | 1.86 M | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 58.09 M | |||
About SomnoMed Performance
By analyzing SomnoMed's fundamental ratios, stakeholders can gain valuable insights into SomnoMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SomnoMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SomnoMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia. Somnomed operates under Medical Devices classification in the United States and is traded on OTC Exchange.Things to note about SomnoMed Limited performance evaluation
Checking the ongoing alerts about SomnoMed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for SomnoMed Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SomnoMed Limited is way too risky over 90 days horizon | |
| SomnoMed Limited has some characteristics of a very speculative penny stock | |
| SomnoMed Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 72.58 M. Net Loss for the year was (4.44 M) with profit before overhead, payroll, taxes, and interest of 44.28 M. | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing SomnoMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SomnoMed's stock is overvalued or undervalued compared to its peers.
- Examining SomnoMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SomnoMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SomnoMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SomnoMed's pink sheet. These opinions can provide insight into SomnoMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SomnoMed Pink Sheet analysis
When running SomnoMed's price analysis, check to measure SomnoMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SomnoMed is operating at the current time. Most of SomnoMed's value examination focuses on studying past and present price action to predict the probability of SomnoMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SomnoMed's price. Additionally, you may evaluate how the addition of SomnoMed to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |